Médica Sur

Hospital Médica Sur Hospital Médica Sur

Joint Commission International Miembro de la Red de Atención Médica de Mayo Clinic Médica Sur

Go to eseñanza gral
Home > Médica Sur Clinic Foundation > Teaching > Colegio de Profesores > Posgrado > Dr. Misael Uribe Esquivel

Dr. Misael Uribe Esquivel

Para actualizar su información contáctenos portalms@medicasur.org.mx

Médico Titular del Curso de Medicina Interna

Departamento: Clínica de Enfermedades Digestivas y Obesidad Mórbida

Universidad o Facultad: Universidad Autónoma de Tamaulipas

Internado Médico:Hospital Civil Carlos Canseco, Tampico, Tamps.

Residencia Médica: Instituto Nacional de la Nutrición Salvador Zubirán / Mayo Clinic Rochester

Certificaciones:

  • Consejo Mexicano de Gastroenterología
  • Consejo Mexicano de Medicina Interna

Áreas de interés:Docencia, Hepatología

 
Conozca las publicaciones de
Misael Uribe Esquivel

(Últimas diez)

  • Sánchez-Muñoz F, Fonseca-Camarillo GC, Villeda-Ramirez MA, Barreto-Zuniga R, Bojalil R, Domínguez-Lopez A, Uribe M, Yamamoto-Furusho JK. TLR9 mRNA expression is upregulated in patients with active ulcerative colitis. Inflamm Bowel Dis. 2010 Aug;16(8):1267-8.
  • Méndez-Sánchez N, García-Villegas E, Merino-Zeferino B, Ochoa-Cruz S, Villa AR, Madrigal H, Kobashi-Margáin RA, Gutiérrez-Grobe Y, Chávez-Tapia N, Ponciano-Rodríguez G, Uribe M. Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states. Ann Hepatol. 2010 Oct 1;9(4):428-38.
  • Gutierrez-Grobe Y, Ponciano-Rodríguez G, Ramos MH, Uribe M, Méndez-Sánchez N. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic síndrome women. The role of estrogens. Ann Hepatol. 2010 Oct 1;9(4):402-9.
  • Yamamoto-Furusho JK, Sánchez-Osorio M, Uribe M. Prevalence and factors associated with the presence of Abnormal Function Liver Tests in patients with ulcerative colitis. Ann Hepatol. 2010 Oct 1;9(4):397-401.
  • Roldan-Valadez E, Favila R, Martínez-López M, Uribe M, Ríos C, Méndez-Sánchez N. In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry. J Hepatol. 2010 Oct;53(4):732-7.
  • Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD002907. Review.
  • Uribe M, Gutiérrez-Grobe Y, Kobashi-Margáin RA, Méndez-Sánchez N. Noninvasive markers of fibrosis in Latin America and Mexico. Ann Hepatol. 2010;9 Suppl:43-8. No abstract available.
  • Uribe M. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C. Latin American Association for the Study of the Liver.  Ann Hepatol. 2010;9 Suppl:8-26.
  • Sixtos-Alonso MS, Sánchez-Muñoz F, Sánchez-Ávila JF, Martínez RA, Domínguez López A, Vargas Vorácková F, Uribe M. IFN-stimulated gene expression is a useful potential molecular marker of response to antiviral treatment with peg-ifn¿ 2b and ribavirin in patients with hepatitis c virus genotype 1. Arch Med Res, 2011 Jan;42(1):28-33.
  • Gutiérrez-Grobe Y, Vitek L, Tiribelli C, Kobashi-Margáin RA, Uribe M, Méndez-Sánchez N. Biliverdin and heme oxygenase antiviral activity against hepatitis c virus. Ann Hepatol 2011 Jan 3;10(1): 105-7.
  • Coss Adame E, Granados J, Uribe M, Torre A. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (aih-pbc) from those with auto-immune hepatitis type 1. Ann Hepatol. 2011 Jan 3;10(1):28.32.